Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 8,199 shares at $9.56 ($79K) on 2007-06-29, disclosed to the SEC on 2007-07-02.
Scheduled sale ($79k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.56 | 600 | $6K | 7.3% |
| 2 | $9.57 | 1,000 | $10K | 12.2% |
| 3 | $9.57 | 200 | $2K | 2.4% |
| 4 | $9.58 | 800 | $8K | 9.8% |
| 5 | $9.59 | 400 | $4K | 4.9% |
| 6 | $9.59 | 3,700 |
| $35K |
| 45.1% |
| 7 | $9.60 | 1,099 | $11K | 13.4% |
| 8 | $9.61 | 400 | $4K | 4.9% |
| Total | $9.59 avg | 8,199 | $79K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |